The VHL gene functions as a tumor-suppressor gene, and mutations inducing loss of function in this gene lead to impaired degradation of hypoxia-inducible factors, promoting abnormal cellular proliferation and tumor formation [1,2]. The gene discussed is VHL; the disease is neoplasm.